Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 194

1.

Paroxetine in panic disorder: clinical management and long-term follow-up.

Dannon PN, Lowengrub K, Iancu I, Kotler M.

Expert Rev Neurother. 2004 Mar;4(2):191-8. Review.

PMID:
15853560
2.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
3.

A naturalistic long-term comparison study of selective serotonin reuptake inhibitors in the treatment of panic disorder.

Dannon PN, Iancu I, Lowengrub K, Gonopolsky Y, Musin E, Grunhaus L, Kotler M.

Clin Neuropharmacol. 2007 Nov-Dec;30(6):326-34.

PMID:
18090457
4.

Treatment of panic disorder: focus on paroxetine.

Pollack MH, Doyle AC.

Psychopharmacol Bull. 2003 Spring;37 Suppl 1:53-63. Review.

PMID:
14566201
5.

The long-term treatment of panic disorder.

Davidson JR.

J Clin Psychiatry. 1998;59 Suppl 8:17-21; discussion 22-3. Review.

6.

Three year naturalistic outcome study of panic disorder patients treated with paroxetine.

Dannon PN, Iancu I, Cohen A, Lowengrub K, Grunhaus L, Kotler M.

BMC Psychiatry. 2004 Jun 11;4:16.

7.

Comorbid cannabis use and panic disorder: short term and long term follow-up study.

Dannon PN, Lowengrub K, Amiaz R, Grunhaus L, Kotler M.

Hum Psychopharmacol. 2004 Mar;19(2):97-101.

PMID:
14994319
8.

Remission rates in patients with anxiety disorders treated with paroxetine.

Ballenger JC.

J Clin Psychiatry. 2004 Dec;65(12):1696-707.

PMID:
15641876
9.

Panic disorder: the place of benzodiazepines and selective serotonin reuptake inhibitors.

Kasper S, Resinger E.

Eur Neuropsychopharmacol. 2001 Aug;11(4):307-21. Review.

PMID:
11532386
11.

A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.

Pollack MH, Lepola U, Koponen H, Simon NM, Worthington JJ, Emilien G, Tzanis E, Salinas E, Whitaker T, Gao B.

Depress Anxiety. 2007;24(1):1-14.

PMID:
16894619
12.

[Pharmacotherapy of panic disorder].

Bougerol T, Farisse J.

Encephale. 1996 Dec;22 Spec No 5:46-53. Review. French.

PMID:
9138947
13.

Review of current treatment in panic disorder.

den Boer JA, Slaap BR.

Int Clin Psychopharmacol. 1998 Apr;13 Suppl 4:S25-30. Review.

PMID:
9690962
14.

Panic disorder: long-term pharmacotherapy and discontinuation.

Rickels K, Schweizer E.

J Clin Psychopharmacol. 1998 Dec;18(6 Suppl 2):12S-18S. Review.

PMID:
9872708
15.

Cognitive behavioral group therapy in panic disorder patients: the efficacy of CBGT versus drug treatment.

Dannon PN, Gon-Usishkin M, Gelbert A, Lowengrub K, Grunhaus L.

Ann Clin Psychiatry. 2004 Jan-Mar;16(1):41-6.

PMID:
15147112
16.

Selective serotonin reuptake inhibitors in the treatment of panic disorder and agoraphobia.

Bakker A, van Balkom AJ, van Dyck R.

Int Clin Psychopharmacol. 2000 Aug;15 Suppl 2:S25-30. Review.

PMID:
11110016
17.

Paroxetine: current status in psychiatry.

Pae CU, Patkar AA.

Expert Rev Neurother. 2007 Feb;7(2):107-20. Review. Erratum in: Expert Rev Neurother. 2007 Mar;7(3):313-4.

PMID:
17286545
18.

Changes in anxiety sensitivity with pharmacotherapy for panic disorder.

Simon NM, Otto MW, Smits JA, Nicolaou DC, Reese HE, Pollack MH.

J Psychiatr Res. 2004 Sep-Oct;38(5):491-5.

PMID:
15380399
19.

Platelet serotonin transporter function after short-term paroxetine treatment in patients with panic disorder.

Kang EH, Shim HB, Kim KJ, Park JE, Lee IS, Yu BH.

Psychiatry Res. 2010 Apr 30;176(2-3):250-3. doi: 10.1016/j.psychres.2008.12.007. Epub 2010 Mar 5.

PMID:
20207008
20.

Predictors of symptom resolution in panic disorder after one year of pharmacological treatment: a naturalistic study.

Marchesi C, Cantoni A, Fontò S, Giannelli MR, Maggini C.

Pharmacopsychiatry. 2006 Mar;39(2):60-5.

PMID:
16555166

Supplemental Content

Support Center